Economic Burden of Lyme Disease: Billions in Costs and Rising
RISING HEALTHCARE COSTS
PERSISTENT SYMPTOMS DRIVE LONG-TERM EXPENSES
THE ECONOMIC BURDEN OF LYME DISEASE CONTINUES TO GROW
The economic burden of Lyme disease extends far beyond the initial tick bite. Persistent symptoms, repeated medical visits, lost productivity, and delayed diagnosis continue to create significant financial strain for patients, families, and the healthcare system.
An estimated 240,000 to 440,000 people are diagnosed with Lyme disease each year, with an average of approximately $3,000 spent annually per patient on treatment, according to a study published in PLOS ONE.
For many patients, the financial impact does not end after a short course of antibiotics. Persistent fatigue, cognitive problems, pain, and autonomic symptoms may continue long after treatment.
For a broader overview of persistent symptoms after treatment, visit our Post-Treatment Lyme Disease Syndrome (PTLDS) guide.
Persistent Symptoms Increase the Economic Burden of Lyme Disease
“Our study looks at the actual costs of treating patients in the year following their Lyme diagnosis,” says study author Emily Adrion, MS. This includes repeated medical visits and diagnostic testing for symptoms that have not resolved after initial treatment.
“It is clear that we need effective, cost-effective and compassionate management of these patients to improve their outcomes even if we don’t know what to call the disease,” Adrion explains.
When diagnosed early, Lyme disease caused by the Borrelia burgdorferi bacteria can often be treated successfully with antibiotics. However, some patients continue to experience symptoms including fatigue, joint pain, muscle pain, and cognitive difficulties.
The persistence and cause of these symptoms remain debated within medicine. Some physicians use the term post-treatment Lyme disease syndrome (PTLDS), while others use chronic Lyme disease when symptoms remain disabling or progressive.
Adrion explains that many patients diagnosed with Lyme disease continue returning for medical care because of persistent symptoms, additional testing, and retreatment.
Healthcare Utilization Continues After Lyme Disease Treatment
The study suggests the severity and prevalence of persistent symptoms following Lyme disease treatment may be underestimated.
Researchers found that 63% of treated Lyme disease patients reported at least one PTLDS-related diagnosis, significantly higher than matched controls without Lyme disease.
Patients with Lyme disease were also:
- 5.5 times more likely to experience excessive fatigue or debility
- 87% more likely to require additional doctor visits
- 71% more likely to visit the emergency room
These findings reinforce the importance of recognizing persistent illness following Lyme disease and improving access to timely diagnosis and individualized care.
Learn more about the challenges of delayed Lyme disease diagnosis and how missed early symptoms may contribute to long-term complications.
Indirect Costs May Exceed Direct Medical Expenses
The economic burden of Lyme disease extends beyond direct medical costs. Lost work productivity, disability, travel expenses, and reduced quality of life often create the largest financial impact.
In a 2010 paper entitled Proof that Chronic Lyme Disease Exists, I discussed the growing societal burden associated with chronic symptoms following Lyme disease.
A 2002 study estimated the mean annual cost of Lyme disease at $16,199 per patient in the United States.
The annual cost of chronic Lyme disease exceeded estimates for several other chronic illnesses, including:
- Fibromyalgia: $10,911 annually
- Rheumatoid arthritis: $10,716 annually
- Lupus: $13,094 annually
Eighty-eight percent of Lyme disease costs were linked to indirect medical expenses, nonmedical costs, and productivity losses rather than direct medical treatment alone.
For additional discussion of persistent symptoms and recovery challenges, visit our Persistent Lyme Disease resource.
The Economic Impact of Lyme Disease May Continue to Rise
In 2002, based on 23,000 reported CDC cases, the annual economic cost of Lyme disease in the United States was estimated at $203 million. Because actual Lyme disease cases are believed to be significantly underreported, the true economic impact may be substantially higher.
Another paper, Insufficient Evidence to Deny Antibiotic Treatment to Chronic Lyme Disease Patients, also highlighted the substantial cost burden associated with persistent illness.
“These patients are lost,” says lead author John Aucott, MD, of Johns Hopkins University School of Medicine. “No one knows what to do with them. It’s a challenge, but the first thing we need to do is recognize this is a problem.”
As Lyme disease cases continue to rise across the United States, the economic burden of delayed diagnosis, persistent symptoms, and repeated medical care may continue to grow as well.
Frequently Asked Questions
How expensive is Lyme disease treatment?
Costs vary widely depending on how early Lyme disease is diagnosed. Patients with persistent symptoms often face repeated medical visits, diagnostic testing, medication costs, and lost productivity.
What contributes most to the economic burden of Lyme disease?
Indirect costs such as missed work, disability, reduced productivity, and long-term symptom management may exceed direct medical treatment expenses.
Can persistent Lyme symptoms increase healthcare use?
Yes. Studies have found that patients with persistent symptoms often require more physician visits, emergency room care, and additional testing after initial treatment.
Does delayed diagnosis increase Lyme disease costs?
Delayed diagnosis may increase the risk of persistent symptoms and prolonged treatment, potentially increasing both medical and nonmedical costs.
Why is the economic burden of Lyme disease difficult to measure?
Many Lyme disease cases are underreported, and indirect costs such as disability and productivity loss are difficult to calculate accurately.
Clinical Takeaway
The economic burden of Lyme disease reflects more than healthcare spending alone. Persistent symptoms, delayed diagnosis, lost productivity, and repeated medical evaluations continue to affect many patients long after initial infection. Recognizing the full impact of Lyme disease may help improve earlier diagnosis, individualized care, and long-term outcomes.
Related Articles
Lyme Disease Misdiagnosis
Recovery From Lyme Disease
Neurologic Lyme Disease
Lyme Disease Symptoms Guide
Autonomic Dysfunction and Lyme Disease
References
- Adrion ER, et al. Health care costs, utilization and patterns of care following Lyme disease. PLoS One. 2015.
- Cameron DJ. Proof that Chronic Lyme Disease Exists. Interdiscip Perspect Infect Dis. 2010.
- Zhang X, et al. Economic impact of Lyme disease. Emerg Infect Dis. 2006.
- Cameron DJL Insufficient Evidence to Deny Antibiotic Treatment to Chronic Lyme Disease Patients.Med Hypotheses. 2009
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
